[
    [
        {
            "time": "2021-03-30",
            "original_text": "医药行业“送水人”泰格医药发布2020年报 净利同比增长107.9%至17.5亿元",
            "features": {
                "keywords": [
                    "泰格医药",
                    "年报",
                    "净利增长",
                    "107.9%",
                    "17.5亿元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业“送水人”泰格医药发布2020年报 净利同比增长107.9%至17.5亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "泰格医药：在手订单充足 期待全球市场突破",
            "features": {
                "keywords": [
                    "泰格医药",
                    "在手订单",
                    "全球市场",
                    "突破"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药：在手订单充足 期待全球市场突破",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "【异动股】泰格医药(03347-HK)涨4.65%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "异动股",
                    "涨4.65%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】泰格医药(03347-HK)涨4.65%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "华金证券 - 泰格医药:业绩略超预期，2021年收入有望保持高速增长",
            "features": {
                "keywords": [
                    "泰格医药",
                    "业绩超预期",
                    "2021年",
                    "高速增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华金证券 - 泰格医药:业绩略超预期，2021年收入有望保持高速增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "高瓴资本概念股普遍强势，公牛、良品铺子、健帆、凯莱英、泰格涨幅居前",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "泰格",
                    "涨幅居前"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍强势，公牛、良品铺子、健帆、凯莱英、泰格涨幅居前",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "国元证券给予泰格医药买入评级，泰格医药2020年报点评：疫情恢复良好，在手订单提速",
            "features": {
                "keywords": [
                    "泰格医药",
                    "买入评级",
                    "疫情恢复",
                    "在手订单提速"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国元证券给予泰格医药买入评级，泰格医药2020年报点评：疫情恢复良好，在手订单提速",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "【浙商|孙建】泰格医药：主业强劲增长，期待国际化进展",
            "features": {
                "keywords": [
                    "泰格医药",
                    "主业强劲增长",
                    "国际化进展"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【浙商|孙建】泰格医药：主业强劲增长，期待国际化进展",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "专注临床研究和注册申报的“卖水人”，做的竟是「富士康」的买卖",
            "features": {
                "keywords": [
                    "泰格医药",
                    "临床研究",
                    "注册申报",
                    "卖水人",
                    "富士康"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "专注临床研究和注册申报的“卖水人”，做的竟是「富士康」的买卖",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "国盛证券 - 泰格医药：业绩符合预期，国际化步伐持续加速",
            "features": {
                "keywords": [
                    "泰格医药",
                    "业绩符合预期",
                    "国际化加速"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国盛证券 - 泰格医药：业绩符合预期，国际化步伐持续加速",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-03-30",
            "original_text": "创新驱动，赋能研发：泰格医药发布2020年度报告",
            "features": {
                "keywords": [
                    "泰格医药",
                    "创新驱动",
                    "赋能研发",
                    "2020年度报告"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "创新驱动，赋能研发：泰格医药发布2020年度报告",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]